Graeme F. Woodworth

Histopathological correlates with survival in reoperated glioblastomas.

Surgical outcomes using a medial-to-lateral endonasal endoscopic approach to pituitary adenomas invading the cavernous sinus.

Emerging insights into barriers to effective brain tumor therapeutics.

Highly compacted pH-responsive DNA nanoparticles mediate transgene silencing in experimental glioma.

Minimizing the non-specific binding of nanoparticles to the brain enables active targeting of Fn14-positive glioblastoma cells.

Preservation of the greater occipital nerve during suboccipital craniectomy results in a paradoxical increase in postoperative headaches.

Highly PEGylated DNA Nanoparticles Provide Uniform and Widespread Gene Transfer in the Brain.

The TWEAK receptor Fn14 is a potential cell surface portal for targeted delivery of glioblastoma therapeutics.

Surface plasmon resonance as a high throughput method to evaluate specific and non-specific binding of nanotherapeutics.

Evolving Drug Delivery Strategies to Overcome the Blood Brain Barrier.

Pathologic deposition of non-amyloid immunoglobulin in the brain leading to mass effect and neurological deficits.

Pulsed ultrasound expands the extracellular and perivascular spaces of the brain.

Non-specific binding and steric hindrance thresholds for penetration of particulate drug carriers within tumor tissue.

Emerging Applications of Therapeutic Ultrasound in Neuro-oncology: Moving Beyond Tumor Ablation.

Repurposing platinum-based chemotherapies for multi-modal treatment of glioblastoma.

Tumor-targeted nanotherapeutics: overcoming treatment barriers for glioblastoma.

Genetically engineered rat gliomas: PDGF-driven tumor initiation and progression in tv-a transgenic rats recreate key features of human brain cancer.

Decreased non-specific adhesivity, receptor targeted (DART) nanoparticles exhibit improved dispersion, cellular uptake, and tumor retention in invasive gliomas.

Cross-species transcriptional analysis reveals conserved and host-specific neoplastic processes in mammalian glioma.

MR-guided transcranial focused ultrasound safely enhances interstitial dispersion of large polymeric nanoparticles in the living brain.

Differential expression of the TWEAK receptor Fn14 in IDH1 wild-type and mutant gliomas.

The TNF receptor family member Fn14 is highly expressed in recurrent glioblastoma and in GBM patient-derived xenografts with acquired temozolomide resistance.

Oxaliplatin disrupts pathological features of glioma cells and associated macrophages independent of apoptosis induction.

Prognostic models for patients with brain metastases after stereotactic radiosurgery with or without whole brain radiotherapy: a validation study.

Developments in Blood-Brain Barrier Penetrance and Drug Repurposing for Improved Treatment of Glioblastoma.

Leveraging Surface Plasmon Resonance to Dissect the Interfacial Properties of Nanoparticles: Implications for Tissue Binding and Tumor Penetration.

Radiosensitization of high-grade gliomas through induced hyperthermia: Review of clinical experience and the potential role of MR-guided focused ultrasound.

Systematic Evaluation of Light-Activatable Biohybrids for Anti-Glioma Photodynamic Therapy.

Predictors and Limitations of the Penetration Depth of Photodynamic Effects in the Rodent Brain.

Decreased nonspecific adhesivity, receptor-targeted therapeutic nanoparticles for primary and metastatic breast cancer.

MCT4 regulates de novo pyrimidine biosynthesis in GBM in a lactate-independent manner.

A multi-center analysis of single-fraction versus hypofractionated stereotactic radiosurgery for the treatment of brain metastasis.

Bone Flap Resorption in Pediatric Patients Following Autologous Cranioplasty.

Leveraging the replication-competent avian-like sarcoma virus/tumor virus receptor-A system for modeling human gliomas.

Elevated fibroblast growth factor-inducible 14 expression transforms proneural-like gliomas into more aggressive and lethal brain cancer.

Localized blood-brain barrier opening in infiltrating gliomas with MRI-guided acoustic emissions-controlled focused ultrasound.

Harnessing nanomedicine for enhanced immunotherapy for breast cancer brain metastases.

Towards controlled drug delivery in brain tumors with microbubble-enhanced focused ultrasound.

Pediatric glioblastoma: mechanisms of immune evasion and potential therapeutic opportunities.

The roles of thermal and mechanical stress in focused ultrasound-mediated immunomodulation and immunotherapy for central nervous system tumors.